Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression (Q34083354)

30 July 2017

title

Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression (English)

1 reference

30 July 2017

main subject

ascending cholangitis

0 references

sclerosing cholangitis

1 reference

primary sclerosing cholangitis

inferred from title

1 reference

3

Kris V Kowdley

1 reference

30 July 2017

1

Emmanouil Sinakos

1 reference

30 July 2017

author name string

Hanns-Ulrich Marschall

2

1 reference

30 July 2017

Alex Befeler

4

1 reference

30 July 2017

Jill Keach

5

1 reference

30 July 2017

Keith Lindor

6

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

30 July 2017

1 reference

30 July 2017

volume

52

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

197-203

1 reference

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928060

Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928060

Clinical features and management of primary sclerosing cholangitis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928060

Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928060

High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928060

Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928060

Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928060

A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928060

Pharmacology of ursodeoxycholic acid, an enterohepatic drug.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928060

Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Part II.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928060

Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928060

Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928060

Transformation of chenodeoxycholic acid and ursodeoxycholic acid by human intestinal bacteria

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928060

High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928060

Effect of colitis and ileoanal pouch on biliary enrichment of ursodeoxycholic acid in primary sclerosing cholangitis

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928060

Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928060

Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928060

Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928060

Intestinal absorption and biliary secretion of ursodeoxycholic acid and its taurine conjugate

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928060

A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928060

High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2928060

Intestinal absorption of ursodeoxycholic acid in patients with extrahepatic biliary obstruction and bile drainage

28 October 2018

1 reference

12 December 2020

Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy

1 reference

12 December 2020

The major metabolites of ursodeoxycholic acid in human urine are conjugated with N-acetylglucosamine

1 reference

12 December 2020

Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: biliary enrichment and biochemical response

1 reference

12 December 2020

Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group

1 reference

12 December 2020

Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver

1 reference

12 December 2020

Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis

1 reference

12 December 2020

Influence of cholestasis on absorption of ursodeoxycholic acid

1 reference

12 December 2020

Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. part I

1 reference

12 December 2020

Identifiers

DOI

10.1002/HEP.23631

1 reference

30 July 2017

1 reference

30 July 2017

1 reference